Dr. Gerald Patrick Morris's lab at UC San Diego focuses on improving organ transplantation success by understanding how the immune system reacts to donor organs. They are developing computational tools to predict the risk of rejection based on genetic factors, particularly HLA alleles. This research aims to personalize immunosuppression strategies, making transplant procedures safer and more effective for patients.

Dr. Nima Mosammaparast's lab at Washington University focuses on understanding how damage to RNA can lead to serious problems with genome stability in cells. Specifically, they investigate a newly discovered pathway where injured RNA causes DNA breaks, potentially leading to genetic disorders or cancer. The lab aims to uncover the factors that recognize and repair these RNA-induced DNA breaks to enhance our understanding of cellular responses to damage.

Dr. Jorge Moscat's lab focuses on understanding the mechanisms of mesenchymal colorectal cancer (CRC), a highly aggressive type of cancer with poor outcomes and limited treatment options. They aim to uncover how cholesterol metabolism contributes to the development of this cancer and how specific proteins can regulate this process. The lab combines mouse models and human data to identify new potential therapies for CRC, which may help overcome its challenges in treatment.

Dr. Anandasankar Ray's research lab at UC Riverside focuses on understanding how mosquitoes detect humans through their sense of smell and taste. By exploring new strategies to create more effective insect repellents and insecticides, the lab aims to reduce human-mosquito interactions and the spread of diseases like malaria and dengue. They utilize innovative AI-based methods to predict and test new compounds that could provide safer and longer-lasting protection for at-risk populations.

Dr. George Z Mentis's lab focuses on understanding how neuronal circuits control movement and how their dysfunction can lead to diseases like spinal muscular atrophy (SMA). The research explores the mechanisms of synaptic dysfunction and the roles of specific neurons in locomotion, aiming to reveal insights into the underlying causes of motor deficits. By using mouse models, the lab seeks to uncover crucial cellular and molecular interactions that contribute to motility disorders, potentially illuminating new therapeutic targets for neurodegenerative diseases.

Dr. Hynek Wichterle's lab at Columbia University focuses on understanding how human spinal motor neurons develop and mature, particularly in comparison to mouse motor neurons. The research aims to identify key molecular mechanisms that contribute to the formation of motor neurons and their susceptibility to diseases like ALS. By engineering specific proteins that could enhance neuron maturation from stem cells, the lab hopes to develop better models of neurodegenerative diseases and explore potential therapeutic strategies.

Dr. Miguel Moutinho's lab at Indiana University Indianapolis focuses on developing innovative therapies for Alzheimer's Disease and tauopathies using existing FDA-approved drugs. By activating a specific receptor in the brain, they aim to enhance neuroprotection and mitigate the pathological effects associated with these neurodegenerative diseases. Their research utilizes various mouse models to evaluate the effectiveness of these treatments and understand the underlying biological mechanisms.

Dr. Christopher V. Nicchitta's research lab at Duke University focuses on understanding how messenger RNAs (mRNAs) are localized and regulated for translation on the endoplasmic reticulum. The lab investigates the role of RNA-binding proteins and the signal recognition particle pathway in mRNA transport processes. Their work aims to uncover how these mechanisms contribute to protein synthesis in different cellular contexts, with implications for developmental biology and diseases.

Dr. Megan Kiely Mueller's lab at Tufts University focuses on understanding how relationships between adolescents and their pet dogs can help young people cope with social anxiety. By exploring the specific dynamics of these relationships, the lab aims to develop effective strategies to support teenagers struggling with mental health issues. The research includes extensive observation and analysis of both behavioral and physiological responses in youth as they interact with their dogs.

Dr. Mary C. Mullins' lab at the University of Pennsylvania focuses on understanding how specific proteins influence the growth and organization of cells during embryonic development, specifically using zebrafish as a model organism. The research examines the roles of Bone Morphogenetic Proteins (BMPs) in signaling pathways that dictate the formation of organs and tissues, as well as investigating the establishment of cell polarity in oocytes which is crucial for proper embryonic development. The findings could be significant for improving therapeutic approaches in tissue engineering and addressing congenital diseases.

Dr. Kenneth M. Murphy's lab at Washington University explores how specific dendritic cells, called cDC1, help the immune system recognize and respond to infections and tumors. The lab focuses on the role of a protein named WDFY4 in both Treg (regulatory T cell) development and antigen presentation, essential for activating the immune response. Their research aims to uncover new treatment pathways for autoimmunity and cancer immunotherapy.

Dr. Mary F. Barbe's lab explores the causes and recovery strategies for musculoskeletal injuries that arise from repetitive overuse. The research focuses on how factors such as sleep quality, inflammation, and fibrosis (scar tissue formation) contribute to pain and dysfunction, particularly as these factors may differ with age and between sexes. The lab tests non-pharmacological interventions like improved sleep and aerobic exercise to see how they can aid recovery in rat models of injury.

Dr. Patricia A Champion's lab at the University of Notre Dame focuses on understanding how pathogenic mycobacteria, like Mycobacterium tuberculosis, cause diseases in humans. They specifically study the ways in which these bacteria adapt to different pH levels in the body and how that impacts their ability to survive and infect. Through innovative research techniques, the lab aims to uncover new insights into treatment and prevention strategies for mycobacterial infections.

Dr. Daniela Cihakova's lab focuses on understanding a serious side effect of cancer treatments known as immune checkpoint inhibitor-associated myocarditis, which can lead to severe heart inflammation and even death in cancer patients. The research explores how certain immune cells in the heart contribute to this condition, particularly after heart injury. By studying these immune responses in mouse models, the lab aims to uncover mechanisms that could lead to new prevention strategies for patients undergoing cancer therapy.

Dr. Jay Naik's lab focuses on understanding how hydrogen sulfide (H2S), a compound naturally produced by our cells, helps regulate blood pressure and blood flow, especially in relation to cardiovascular diseases. The lab explores how the content of cholesterol in endothelial cells affects their ability to use H2S for vasodilation, which is crucial for maintaining healthy blood circulation. This research aims to uncover new therapeutic targets to treat cardiovascular conditions like hypertension and stroke.

Dr. Seung Ha Nam's lab at Weill Medical College focuses on studying blood disorders known as myeloproliferative neoplasms (MPNs), particularly how genetic mutations affect responses to treatment. Using advanced techniques like single-cell sequencing, the lab investigates why some patients respond well to interferon therapy while others develop resistance. By understanding these mechanisms, the lab aims to develop more effective therapeutic strategies for treating MPNs.

Dr. William H. Gmeiner's lab focuses on developing innovative nanotechnology solutions to enhance cancer treatment, specifically for metastatic colorectal cancer (mCRC). Their research is particularly centered on a specialized polymer designed to improve drug delivery and effectiveness while reducing toxicity. By utilizing advanced formulations, such as lipid nanoparticles, they aim to directly target tumors and improve the outcomes of chemotherapy.

Dr. Nanette M Nascone-Yoder's lab focuses on understanding how the stomach develops its unique leftward curvature during embryonic growth. They study the processes that lead to left-right asymmetries in stomach anatomy, which are crucial for preventing birth defects known as heterotaxy. Using both frog embryos and computer simulations, the lab aims to uncover the tissue-level mechanisms behind normal and abnormal stomach formation.

Dr. Aharon G Freud's lab at Ohio State University studies natural killer (NK) cells, which are crucial for the immune system's ability to fight cancer. They focus on understanding how these cells develop in healthy situations and how their function is altered during endometrial carcinoma, a common type of cancer affecting women. By investigating the cellular and molecular mechanisms behind NK cell development, the lab aims to discover new ways to boost the immune response against cancer.

Dr. Martin Chalfie's lab at Columbia University focuses on understanding how nerve cells differentiate and function using the model organism, the nematode worm Caenorhabditis elegans. His research explores genetic mechanisms behind neuronal development, particularly in touch receptor neurons, and how these insights could relate to human health and disease. The lab employs advanced techniques to analyze gene functions that may enhance our understanding of mechanosensation and the cellular processes involved in nervous system disorders.